F.D.A. Actos Update

Posted on Saturday, September 17th, 2011 at 8:19 pm    

In June, the FDA published this FDA Drug Safety Communication related to the use of the drug Actos and Actos Combinations.  In the Communication, the FDA stated the following: “The U.S. Food and Drug Administration (FDA) is informing the public that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with […]

Actos and Bladder Cancer-Mississippi Attorney

Posted on Thursday, September 8th, 2011 at 10:36 pm    

Actos and Actos Combinations are drugs used to to treat type 2 Diabetes.  They increase the body’s sensitivity to insulin.  Actos is also known as Pioglitazone. The FDA has recently notified healthcare professionals and patients that the Agency is revieiwing data from an ongoing, ten year epidemiological study designed to evaluate whether Actos and associated drugs are associated […]